Skip to main content

Table 2 Clinical biochemical analyses of the study population

From: Transition of the genital mollicutes from the second to the third trimester of pregnancy and its association with adverse pregnancy outcomes in GDM women: a prospective, single-center cohort study from China

Variables

(-/-) No. (%)

(+/-) No. (%)

(-/+) No. (%)

(+/+) No. (%)

F/χ2

P

All participants

191

65

95

81

  

Blood lipids

      

 Total cholesterol, mmol/L (mean ± SD)

5.04 ± 0.94

5.16 ± 1.01

5.17 ± 0.99

4.90 ± 0.81

0.25

0.62

  0.00-5.20

123 (64.40)

43 (66.15)

56 (58.95)

57 (70.37)

2.58

0.46

  ≥ 5.21

68 (35.60)

22 (33.85)

39 (41.05)

24 (29.63)

  

  Missing

0

0

0

0

  

 Low density lipoprotein cholesterol, mmol/L (mean ± SD)

2.48 ± 0.70

2.58 ± 0.66

2.53 ± 0.73

2.35 ± 0.62

0.96

0.33

  0.00-3.10

158 (82.72)

52 (80.00)

73 (76.84)

71 (87.65)

3.70

0.30

  ≥ 3.11

33 (17.28)

13 (20.00)

22 (23.16)

10 (12.35)

  

  Missing

0

0

0

0

  

 High density lipoprotein cholesterol, mmol/L (mean ± SD)

1.85 ± 0.34

1.78 ± 0.37

1.87 ± 0.37

1.86 ± 0.34

0.11

0.74

  0.00-1.80

86 (45.50)

35 (53.85)

40 (42.11)

41 (51.25)

2.89

0.41

  ≥ 1.81

103 (54.50)

30 (46.15)

55 (57.89)

39 (48.75)

  

  Missing

2

0

0

1

  

 Triglyceride, mmol/L (mean ± SD)

1.60 ± 0.77

1.93 ± 1.01

1.70 ± 0.75

1.56 ± 0.66

0.01

0.95

  0.00-1.70

128 (67.02)

34 (52.31)

60 (63.16)

59 (72.84)

7.28

0.06

  ≥ 1.71

63 (32.98)

31 (47.69)

35 (36.84)

22 (27.16)

  

  Missing

0

0

0

0

  

Nutrition/immune indicators

      

 Albumin, g/L (mean ± SD)

41.96 ± 3.43

41.83 ± 3.53

41.97 ± 3.78

42.38 ± 3.67

21.73

0.24

  < 40.00

44 (23.04)

16 (24.62)

25 (26.32)

16 (19.75)

1.12

0.77

  40.00–55.00

147 (76.96)

49 (75.38)

70 (73.68)

65 (80.25)

  

  Missing

0

0

0

0

  

 Globulin, g/L (mean ± SD)

26.81 ± 3.53

27.23 ± 4.05

27.19 ± 3.78

27.44 ± 4.06

0.55

0.46

  < 20.00

3 (1.57)

0 (0.00)

1 (1.05)

2 (2.47)

-

0.75a

  20.00–40.00

188 (98.43)

65 (100.00)

94 (98.95)

79 (97.53)

  

  Missing

0

0

0

0

  

Hepatic function indexes

      

 Alanine aminotransferase, U/L (Median, Quantile)

17.99 ± 12.65

18.71 ± 13.92

20.11 ± 17.11

21.62 ± 24.59

3.02

0.08

  < 7.00

13 (6.81)

5 (7.69)

3 (3.16)

3 (3.70)

-

0.66a

  7.00–40.00

166 (86.91)

56 (86.15)

83 (87.37)

70 (86.42)

  

  ≥ 40.01

12 (6.28)

4 (6.15)

9 (9.47)

8 (9.88)

  

  Missing

0

0

0

0

  

 Aspartate aminotransferase, U/L (mean ± SD)

19.70 ± 6.81

19.80 ± 6.55

20.24 ± 8.23

20.91 ± 12.38

1.19

0.28

  < 13.00

17 (8.90)

5 (7.69)

10 (10.53)

3 (3.70)

 

0.36a

  13.00–35.00

170 (89.01)

59 (90.77)

80 (84.21)

74 (91.36)

  

  ≥ 35.01

4 (2.09)

1 (1.54)

5 (5.26)

4 (4.94)

  

  Missing

0

0

0

0

  
  1. Note: a Fisher exact test were used. Data presented as n (%), unless noted otherwise. Participants were grouped based on the second and third trimester infection status as: uninfected in either trimester (-/-), merely infected in the second trimester (+/-), merely infected in the third trimester (-/+), infected in both trimesters (+/+). Abbreviations: SD = standard deviation
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us